Grants and Contributions:
Title:
Spectral Elimination of Melanin Effects on Tissue Oxygenation Staturation (STO2) Measurements
Agreement Number:
875439
Agreement Value:
$477,000.00
Agreement Date:
Oct 1, 2016 - Feb 28, 2019
Description:
It is the objective of this project to develop technology that can identify, measure and compensate for the optical attenuation effects of melanin on the oxygen saturation data obtained from tissue through multispectral reflectance imaging.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Calgary, Alberta, CA T2R 1M5
Reference Number:
172-2018-2019-Q2-875439
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
803258870
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 243 days. The total amended value is 130,000 dollars.
Amendment Date
Jul 19, 2018
Recipient's Legal Name:
Kent Imaging Inc.
Federal Riding Name:
Calgary Centre
Federal Riding Number:
48004
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
417930
Amendments: